Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies - Financial Times

1. Novo Nordisk and Pfizer sweeten offers for Metsera as bidding war intensifies  Financial Times
2. Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer  CNBC
3. Delaware Judge Does Not See Current Need for Court in Metsera Bidding War Between Pfizer and Novo  U.S. News & World Report
4. Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga  Bloomberg.com
5. Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera  Reuters